You will work on a research programme, funded by the Department of Health Policy Research Programme, aimed at generating new evidence on the cost-effectiveness of interventions targeted at infectious diseases in England. The precise infections and interventions considered will by driven by Department of Health policy makers, but the initial focus will be on finalising an individual-based model of the effects of PCV (pneumococcal conjugate) vaccines.

You will be based in Warwick Clinical Trials Unit, Warwick Medical School, but will work closely with other researchers at the University of Warwick with considerable expertise in this area, particularly colleagues at the Warwick Zeeman Institute for Systems Biology & Infectious Disease Epidemiology Research (SBIDER). Close working and regular communication between the post holder and the other mathematical modellers and health economists will be crucial to the successful delivery of the research programme. You will have day-to-day responsibility for the development of transmission models, including parameterisation of the models through critical reviews of relevant literature and analysis of appropriate datasets, identification of knowledge gaps and, where appropriate, primary research aimed at addressing those gaps. In collaboration with the other mathematical modellers and health economists, you will have day-to-day responsibility for estimating variability, uncertainty and heterogeneity in cost-effectiveness results.

You will be expected to respond to the needs of Department of Health policy makers who make decisions regarding public health interventions against infectious diseases. You will also be expected to disseminate the outputs of your research in the form of reports to the Department of Health and publications in peer-reviewed journals.